Age-related difference in the sleep pressure-lowering effect between an Angiotensin II receptor blocker and a calcium channel blocker in Asian Hypertensives: The ACS1 study

Hypertension

Volumn 65, Issue 4, 2015, Pages 729-735

  Kario, Kazuomi ^a   Hoshide, Satoshi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

ambulatory blood pressure monitoring; amlodipine; azilsartan; control rate; hypertension

Indexed keywords

AMLODIPINE; AZILSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; OXADIAZOLE DERIVATIVE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; SLEEP; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS; AGED; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECTS; INCIDENCE; JAPAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; MALE; MIDDLE AGED; OXADIAZOLES; SLEEP; TREATMENT OUTCOME;

EID: 84929134323     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04935     Document Type: Article

References (23)

1. Boggia J, Li Y, Thijs L, et al; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007; 370: 1219-1229. doi: 10.1016/S0140-6736(07)61538-4
2. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996; 27: 130-135
3. Cuspidi C, Macca G, Sampieri L, Fusi V, Severgnini B, Michev I, Salerno M, Magrini F, Zanchetti A. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens. 2001; 19: 1539-1545
4. Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, Miyagi S, Yoshida A, Kimura G. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension. 2008; 52: 1155-1160. doi: 10.1161/HYPERTENSIONAHA.108.115329
5. Rakugi H, Enya K, Sugiura K, Ikeda Y. Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study. Hypertens Res. 2012; 35: 552-558. doi: 10.1038/hr.2012.8
6. Sica D, White WB, Weber MA, Bakris GL, Perez A, Cao C, Handley A, Kupfer S. Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2011; 13: 467-472. doi: 10.1111/j.1751-7176.2011.00482.x
7. Rakugi H, Kario K, Enya K, Igeta M, Ikeda Y. Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension. Blood Press. 2013; 22 Suppl 1: 22-28. doi: 10.3109/08037051.2013.818758
8. Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997; 10: 261-268
9. Mounier-Véhier C, Jaboureck O, Emeriau JP, Bernaud C, Clerson P, Carre A. Randomized, comparative, double-blind study of amlodipine vs. nicardipine as a treatment of isolated systolic hypertension in the elderly. Fundam Clin Pharmacol. 2002; 16: 537-544
10. Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther. 2003; 17: 335-341
11. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, Ishikawa S, Shimada K. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens. 2004; 17: 112-117
12. Kario K, Hoshide S. Rationale, study design, and implementation of the ACS1 study: effect of azilsartan on circadian and sleep blood pressure as compared with amlodipine. Blood Press Monit. 2014; 19: 123-128. doi: 10.1097/MBP.0000000000000032
13. O'Brien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013; 31: 1731-1768. doi: 10.1097/HJH.0b013e328363e964
14. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014; 16: 14-26. doi: 10.1111/jch.12237
15. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. doi: 10.1001/jama.2013.284427
16. Nelson M. Drug treatment of elevated blood pressure. Aust Prescr. 2010; 33: 108-112
17. Kohara Y, Kubo K, Imamiya E, Wada T, Inada Y, Naka T. Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres. J Med Chem. 1996; 39: 5228-5235. doi: 10.1021/jm960547h
18. Wang JG, Kario K, Lau T, Wei YQ, Park CG, Kim CH, Huang J, Zhang W, Li Y, Yan P, Hu D; Asian Pacific Heart Association. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association. Hypertens Res. 2011; 34: 423-430. doi: 10.1038/hr.2010.259
19. Kario K. Proposal of a new strategy for ambulatory blood pressure profilebased management of resistant hypertension in the era of renal denervation. Hypertens Res. 2013; 36: 478-484. doi: 10.1038/hr.2013.19
20. Shimamoto K, Ando K, Fujita T, et al; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014; 37: 253-390. doi: 10.1038/hr.2014.20
21. Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens. 2001; 14: 241-247
22. National Clinical Guideline Centre. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: National Clinical Guideline Centre; 2011
23. Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008; 336: 1121-1123